ERROR:
JavaScript is not enabled. You must enable JavaScript in your browser to use this form
Please fill in a valid value for all required fields
Please ensure all values are in a proper format.
Are you sure you want to leave this form and resume later?
Are you sure you want to leave this form and resume later? If so, please enter a password below to securely save your form.
Save and Resume Later
Save and get link
You must upload one of the following file types for the selected field:
There was an error displaying the form. Please copy and paste the embed code again.
Apply Discount
You saved
with code
Submit Form
Submitting
Validating
There was an error initializing the payment processor on this form. Please contact the form owner to correct this issue.
Please check the field:
Fields
Name
*
First Name
*
Last Name
*
Profession
*
Physician
Other:
Other Value
Email
*
Select the date you attended:
*
June 10, 2021 | Virtual Event
July 9, 2021 | Virtual Event
August 7, 2021 in Miramar Beach, FL
August 14, 2021 in Orlando, FL
November 6, 2021 in Portland, ME
November 9, 2021 | Virtual Event
November 10, 2021 | Virtual Event
February 4, 2022 Hybrid Event out of San Diego, CA
March 5, 2022 | Virtual Event
May 21, 2022 | Waltham, MA
June 6, 2022 | Virtual Event
Post Test
1. Isolated post-capillary pulmonary arterial hypertension is defined hemodynamically as ______________.
*
A. Mean arterial pressure of >10 mmHg, pulmonary capillary wedge pressure >25 mmHg, and a pulmonary vascular resistance <2 Woods Units
B. Mean arterial pressure of >10 mmHg, pulmonary capillary wedge pressure >25 mmHg, and a pulmonary vascular resistance <3 Woods Units
C. Mean arterial pressure of >20 mmHg, pulmonary capillary wedge pressure >15 mmHg, and a pulmonary vascular resistance <3 Woods Units
D. Mean arterial pressure of >15 mmHg, pulmonary capillary wedge pressure >10 mmHg, and a pulmonary vascular resistance <2Woods Units
2. According to the 6th World Symposium on Pulmonary Hypertension, combined pre- and post-capillary pulmonary hypertension is classified as ________________________.
*
A. Group 1 and 2
B. Group 1 and 5
C. Group 2 and 4
D. Group 2 and 5
3. Chronic thromboembolic pulmonary hypertension (CTEPH) may be cured with ________________________.
*
A. Pulmonary thromboendarterectomy (PTE)
B. Riociguat
C. Phosphodiesterase 5 inhibitors
D. Transcatheter aortic valve replacement (TAVR)
4. Which of the following is not a common side effect associated with soluble guanylate cyclase stimulators (sGC)?
*
A. Headache
B. Dizziness
C. Dyspepsia/gastritis
D. Nosebleeds
5. A 45-year-old patient with a known history of pulmonary hypertension secondary to valvular heart disease has recently moved to your area. She is a WHO functional class 4, with frequently repeated syncope, a Peak VO2 of 7 ml/min/kg, an NT-proBNP of 1470 ng/l, and a right atrial pressure of 16 mmHg. What would be the best management option for this patient?
*
A. She should be managed collaboratively with a specialty PH care center.
B. She should be referred to a local cardiology clinic.
C. She may be managed by her general practitioner as long as her right atrial pressure remains under 20 mmHg.
D. She should contact her insurance provider to determine her local coverage options.
Evaluation
Average years in practice:
*
<5
5-10
11-15
16-20
21-25
>25
Average number of patients seen per week with disease targeted in the education:
*
<5
5-10
11-15
16-20
21-25
>25
After participating in this activity I am better prepared to:
*
After participating in this activity I am better prepared to:
Strongly Agree
Agree
Disagree
Strongly Disagree
Discuss the clinical presentation, hemodynamic definitions, and diagnosis of pulmonary arterial hypertension and post-capillary pulmonary hypertension related to left heart disease
After participating in this activity I am better prepared to:: Discuss the clinical presentation, hemodynamic definitions, and diagnosis of pulmonary arterial hypertension and post-capillary pulmonary hypertension related to left heart disease (Strongly Agree)
Discuss the clinical presentation, hemodynamic definitions, and diagnosis of pulmonary arterial hypertension and post-capillary pulmonary hypertension related to left heart disease (Agree)
Discuss the clinical presentation, hemodynamic definitions, and diagnosis of pulmonary arterial hypertension and post-capillary pulmonary hypertension related to left heart disease (Disagree)
Discuss the clinical presentation, hemodynamic definitions, and diagnosis of pulmonary arterial hypertension and post-capillary pulmonary hypertension related to left heart disease (Strongly Disagree)
Review the recommended treatment for pulmonary arterial hypertension
Review the recommended treatment for pulmonary arterial hypertension (Strongly Agree)
Review the recommended treatment for pulmonary arterial hypertension (Agree)
Review the recommended treatment for pulmonary arterial hypertension (Disagree)
Review the recommended treatment for pulmonary arterial hypertension (Strongly Disagree)
Identity a collaborative care management approach for patients with pulmonary arterial hypertension
Identity a collaborative care management approach for patients with pulmonary arterial hypertension (Strongly Agree)
Identity a collaborative care management approach for patients with pulmonary arterial hypertension (Agree)
Identity a collaborative care management approach for patients with pulmonary arterial hypertension (Disagree)
Identity a collaborative care management approach for patients with pulmonary arterial hypertension (Strongly Disagree)
The activity was appropriate and met my educational needs.
*
Strongly Agree
Agree
Disagree
Strongly Disagree
The speaker demonstrated experiential knowledge of the topic.
*
Strongly Agree
Agree
Disagree
Stongly Disagree
The educational materials were effective.
*
Strongly Agree
Agree
Disagree
Strongly Disagree
The faculty was knowledgeable, effective and free of bias.
*
Strongly Agree
Agree
Disagree
Strongly Disagree
The content was relevant to my practice.
*
Strongly Agree
Agree
Disagree
Strongly Disagree
The design of the program was effective for the content conveyed.
*
Strongly Agree
Agree
Disagree
Strongly Disagree
The learning activities were effective and incorporated active learning methods.
*
Strongly Agree
Agree
Disagree
Strongly Disagree
The content of this activity contributes valuable information that will assist me in improving patient outcomes.
*
Strongly Agree
Agree
Disagree
Strongly Disagree
The content provided a fair and balanced coverage of the topic.
*
Strongly Agree
Agree
Disagree
Strongly Disagree
The content was objective, current, scientifically sound and free of commercial bias.
*
Yes
No
If no, please explain:
Overall, I was satisfied with the activity.
*
Strongly Agree
Agree
Disagree
Strongly Disagree
Based on information presented in the activity, I will:
*
Do nothing because content was not convincing
Change my practice
Seek additional information on this topic
Do nothing as current practice reflects activity recommendations
Do nothing as lack of organizational support prevents my adoption of presented guidelines and recommendations
Do nothing as lack of financial support prevents my adoption of presented guidelines and recommendations
Other:
Other Value
As a result of this course, I will likely make changes to my practice in these categories:
*
Diagnosis
Documentation (appropriate)
Patient Education
Patient Safety
Treatment Approach
Medication
The most important concept(s) I learned during this activity that may effect a change in patient care is:
As a result of my participation in this activity, I plan to make the following change in my role on the healthcare team:
Based on the objectives above and participation in the activity, my healthcare team will make the following changes in practice:
Please suggest any other future topics you would be interested in:
Comments
CE Provided by AKH Inc., Advancing Knowledge in Healthcare
Previous
←
Next
→
Enter your save and resume password
Cancel
Confirm